Skip to main content

Advertisement

SpringerLink
Log in

Medical Management of Pain in Chronic Pancreatitis

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The medical management of pain in chronic pancreatitis continues to pose significant challenges for clinicians caring for these patients. There are increasing data, suggesting that pain in chronic pancreatitis is largely due to peripheral and central sensitization that evolves, over time, as a result of nociceptive afferent associated with chronic inflammation and fibrosis of the pancreas. In many instances, patients rapidly progress to requiring opioid analgesics for the adequate treatment of pain despite the unequivocal risks associated with the long-term use of these drugs. Centrally acting drugs, such as gabapentinoids, appear to be effective means of treating pain due to their inhibition of neurotransmitters involved in central sensitization, but side effects limit their use. The present review explores the evidence for various non-pharmacologic and pharmacologic treatments for pain in chronic pancreatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilization in chronic pancreatitis: a prospective cohort study. Gut. 2011;60:77–84.

    Article  PubMed  Google Scholar 

  2. Machicado JD, Amann ST, Anderson MA, et al. Quality of life in chronic pancreatitis is determined by constant pain, disability/unemployment, current smoking, and associated co-morbidities. Am J Gastroenterol. 2017;112:633–642.

    Article  PubMed  Google Scholar 

  3. Mokrowiecka A, Pinkowski D, Malecka-Panas E, et al. Clinical, emotional and social factors associated with quality of life in chronic pancreatitis. Pancreatology. 2010;10:39–46.

    Article  CAS  PubMed  Google Scholar 

  4. Olesen SS, Jeul J, Nielsen AK, et al. Pain severity reduces quality of life in chronic pancreatitis: implications for design of future outcome trials. Pancreatology. 2014;14:497–502.

    Article  PubMed  Google Scholar 

  5. Conwell DL, Lee LS, Yadav D, et al. American Pancreatic Association practice guidelines in chronic pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014;43:1143–1162.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lohr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEu). United Eur Gastroenterol J. 2017;5:153–199.

    Article  Google Scholar 

  7. Bhutani MS, Arantes VN, Verma D, et al. Histopathologic correlation of endoscopic ultrasound findings of chronic pancreatitis in human autopsies. Pancreas. 2009;38:820–824.

    Article  PubMed  Google Scholar 

  8. Detlefsen S, Sipos B, Feyerabend B, et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch. 2005;447:800–805.

    Article  PubMed  Google Scholar 

  9. Pitchumoni CS, Glasser M, Saran RM, et al. Pancreatic fibrosis in chronic alcoholics and nonalcoholics without clinical pancreatitis. Am J Gastroenterol. 1984;79:382–388.

    CAS  PubMed  Google Scholar 

  10. van Geenen EJ, Smits MM, Schreuder TC, et al. Smoking is related to pancreatic fibrosis in humans. Am J Gastroenterol. 2011;106:1161–1166.

    Article  PubMed  Google Scholar 

  11. Avram MM. High prevalence of pancreatic disease in chronic renal failure. Nephron. 1977;18:68–71.

    Article  CAS  PubMed  Google Scholar 

  12. Mohapatra S, Majumder S, Smyrk TC, et al. Diabetes mellitus is associated with an exocrine pancreatopathy: conclusions from a review of the literature. Pancreas. 2016;45:1104–1110.

    Article  PubMed  Google Scholar 

  13. Trikudanathan G, Vega-Peralta J, Malli A, et al. Diagnostic performance of endoscopic ultrasound (EUS) for non-calcific chronic pancreatitis (NCCP) based on histopathology. Am J Gastroenterol. 2016;111:568–574.

    Article  CAS  PubMed  Google Scholar 

  14. Jones SN, McNeil NI, Lees WR. The interpretation of retrograde pancreatography in the elderly. Clin Radiol. 1989;40:393–396.

    Article  CAS  PubMed  Google Scholar 

  15. Kizu M, Newmann J, Cotton PB, Kasugai T. Histological correlation with pancreatography in necropsy specimens. Gut. 1977;18:399–400.

    Google Scholar 

  16. Wilcox CM, Yadav D, Ye T, et al. Chronic pancreatitis pain pattern and severity are independent of abdominal imaging findings. Clin Gastroenterol Hepatol. 2015;13:552–560.

    Article  PubMed  Google Scholar 

  17. Frokjaer JB, Olesen SS, Drewes AM. Fibrosis, atrophy, and ductal pathology in chronic pancreatitis are associated with pancreatic function but independent of symptoms. Pancreas. 2013;42:1182–1187.

    Article  CAS  PubMed  Google Scholar 

  18. Bahuva R, Walsh RM, Kapural L, et al. Morphologic abnormalities are poorly predictive of visceral pain in chronic pancreatitis. Pancreas. 2013;42:6–10.

    Article  PubMed  Google Scholar 

  19. Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16:218–224.

    Article  PubMed  Google Scholar 

  20. Anderson MA, Akshintala V, Albers KM, et al. Mechanism, assessment and management of pain in chronic pancreatitis: recommendations of a multidisciplinary study group. Pancreatology. 2016;16:83–94.

    Article  PubMed  Google Scholar 

  21. Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. Pancreatic neuropathy and neuropathic pain—a comprehensive pathomorphological study of 546 cases. Gastroenterology. 2009;136:177–186.

    Article  PubMed  Google Scholar 

  22. Pasricha PJ. Unraveling the mystery of pain in chronic pancreatitis. Nat Rev Gastroenterol Hepatol. 2012;9:140–151.

    Article  CAS  PubMed  Google Scholar 

  23. Bouwense SA, de Vries M, Schreuder LT, et al. Systematic mechanism-oriented approach to chronic pancreatitis pain. World J Gastroenterol. 2015;21:47–59.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Drewes AM, Krarup AL, Detlefsen S, et al. Pain in chronic pancreatitis: the role of neuropathic pain mechanisms. Gut. 2008;57:1616–1627.

    Article  CAS  PubMed  Google Scholar 

  25. Buscher HC, Wilder-Smith OH, van Goor H. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain. 2006;10:363–370.

    Article  PubMed  Google Scholar 

  26. Dimcevski G, Sami SA, Funch-Jensen P, et al. Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology. 2007;132:1546–1556.

    Article  PubMed  Google Scholar 

  27. Olesen SS, Frokjaer JB, Lelic D, et al. Pain-associated adaptive cortical reorganization in chronic pancreatitis. Pancreatology. 2010;10:742–751.

    Article  PubMed  Google Scholar 

  28. Frojkaer JB, Olesen SS, Gram M, et al. Altered brain microstructure assessed by diffusion tensor imaging in patients with chronic pancreatitis. Gut. 2011;60:1554–1562.

    Article  Google Scholar 

  29. Frokjaer JB, Bouwense SA, Olesen SS, et al. Reduced cortical thickness of brain areas involved in pain processing in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2012;10:434–438.

    Article  PubMed  Google Scholar 

  30. de Vries M, Wilder-Smith OH, Jongsma ML, et al. Altered resting state EEG in chronic pancreatitis patients: toward a marker for chronic pain. J Pain Res. 2013;6:815–824.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Jongsma M, Postma SA, Souren P, et al. Neurodegenerative properties of chronic pain: cognitive decline in patients with chronic pancreatitis. PLoS ONE. 2011;6:e23363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Teo K, Johnson MH, Truter S, et al. Pain assessment in chronic pancreatitis: a comparative review of methods. Pancreatology. 2016;16:931–939.

    Article  CAS  PubMed  Google Scholar 

  33. Capurso G, Cocomello L, Benedetto U, et al. Meta-analysis: the placebo rate of abdominal pain remission in clinical trials of chronic pancreatitis. Pancreas. 2012;41:1125–1131.

    Article  PubMed  Google Scholar 

  34. Strum WB. Abstinence in alcoholic chronic pancreatitis: effect on pain and outcome. J Clin Gastroenterol. 1995;20:37–41.

    Article  CAS  PubMed  Google Scholar 

  35. De Las HG, de la Pena J, Lopez Arias MJ, et al. Drinking habits and pain in chronic pancreatitis. J Clin Gastroenterol. 1995;20:33–36.

    Article  Google Scholar 

  36. Talamini G, Bassi C, Falconi M, et al. Pain relapses in the first 10 years of chronic pancreatitis. Am J Surg. 1996;171:565–569.

    Article  CAS  PubMed  Google Scholar 

  37. Hans S, Kheder J, Bocelli L, et al. Smoking cessation in a chronic pancreatitis population. Pancreas. 2016;45:1303–1308.

    Article  Google Scholar 

  38. Durbec JP, Sarles H. Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreatitis and alcohol, protein and lipid consumption. Digestion. 1978;18:337–350.

    Article  CAS  PubMed  Google Scholar 

  39. Pitchumoni CS, Sonnenshein M, Candido FM, et al. Nutrition in the pathogenesis of alcoholic pancreatitis. Am J Clin Nutr. 1980;33:631–636.

    CAS  PubMed  Google Scholar 

  40. Mezey E, Kolman CJ, Diehl AM, et al. Alcohol and dietary intake in the development of chronic pancreatitis and liver disease in alcoholism. Am J Clin Nutr. 1988;48:148–151.

    CAS  PubMed  Google Scholar 

  41. Levy P, Mathurin P, Roqueplo A, et al. A multidimensional case-control study of dietary, alcohol, and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas. 1995;10:231–238.

    Article  CAS  PubMed  Google Scholar 

  42. Castineira-Alvarino M, Lindkvist B, Luaces-Requeira M, et al. The role of high fat diet in the development of complications of chronic pancreatitis. Clin Nutr. 2013;32:830–836.

    Article  CAS  PubMed  Google Scholar 

  43. Ito T, Igarashi H, Niina Y, et al. Management of pain in chronic pancreatitis with home elemental diet ingestion. JOP. 2010;11:648–649.

    PubMed  Google Scholar 

  44. Kataoka K, Sakagami J, Hirota M, et al. Effects of oral ingestion of the elemental diet in patients with painful chronic pancreatitis in the real-life setting in Japan. Pancreas. 2014;43:451–457.

    Article  CAS  PubMed  Google Scholar 

  45. Ikeura T, Takaoka M, Uchida K, et al. Beneficial effect of low-fat elemental diet therapy on pain in chronic pancreatitis. Int J Chronic Dis. 2014;2014:862091.

    PubMed  PubMed Central  Google Scholar 

  46. O’Keefe SJ, Lee RB, Anderson FP, et al. Physiological effects of enteral and parenteral feeding on pancreaticobiliary secretion in humans. Am J Physiol Gastrointest Liver Physiol. 2003;284:G27–G36.

    Article  PubMed  Google Scholar 

  47. Bouwense SA, Olesen SS, Drewes AM, et al. Is altered central pain processing related to disease stage in chronic pancreatitis patients with pain? An exploratory study. PLoS ONE. 2013;8:e55460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Shea JC, Bishop MD, Parker EM, et al. An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology. 2003;3:36–40.

    Article  CAS  PubMed  Google Scholar 

  49. Kaushik N, Pietraszewski M, Holst JJ, et al. Enteral feeding without pancreatic stimulation. Pancreas. 2005;31:353–359.

    Article  PubMed  Google Scholar 

  50. Skipworth JR, Raptis DA, Wijesuriya S, et al. The use of nasojejunal nutrition in patients with chronic pancreatitis. JOP. 2011;12:574–580.

    PubMed  Google Scholar 

  51. Stanga Z, Giger U, Marx A, et al. Effect of jejunal long-term feeding in chronic pancreatitis. JPEN J Parenter Enteral Nutr. 2005;29:12–20.

    Article  PubMed  Google Scholar 

  52. Chowdhury RS, Forsmark CE, Davis RH, et al. Prevalence of gastroparesis in patients with small duct chronic pancreatitis. Pancreas. 2003;26:235–238.

    Article  PubMed  Google Scholar 

  53. John GK, Singh VK, Moran RA, et al. Chronic gastrointestinal dysmotility and pain following total pancreatectomy with islet autotransplantation for chronic pancreatitis. J Gastrointest Surg. 2017;21:622–627.

    Article  PubMed  Google Scholar 

  54. Funakoshi A, Nakano I, Shinozaki H, et al. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain. Am J Gastroenterol. 1986;81:1174–1178.

    CAS  PubMed  Google Scholar 

  55. van Esch AA, Ahmed Ali U, van Goor H, et al. A wide variation in diagnostic and therapeutic strategies in chronic pancreatitis: a Dutch national survey. JOP. 2012;13:394–401.

    PubMed  Google Scholar 

  56. Burton F, Alkaade S, Collins D, et al. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. Aliment Pharmacol Ther. 2011;33:149–159.

    Article  CAS  PubMed  Google Scholar 

  57. Yaghoobi M, McNabb-Baltar J, Bijarchi R, et al. Pancreatic enzyme supplements are not effective for relieving abdominal pain in patients with chronic pancreatitis: meta-analysis and systematic review of randomized controlled trials. Can J Gastroenterol Hepatol. 2016;2016:8541839.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Morris-Stiff GJ, Bowrey DJ, Oleesky D, et al. The antioxidant profiles of patients with recurrent acute and chronic pancreatitis. Am J Gastroenterol. 1999;94:2135–2140.

    Article  CAS  PubMed  Google Scholar 

  59. Talukdar R, Murthy HV, Reddy DN. Role of methionine containing antioxidant combination in the management of pain in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology. 2015;15:136–144.

    Article  CAS  PubMed  Google Scholar 

  60. Cai GH, Huang J, Zhao Y, et al. Antioxidant therapy for pain relief in patients with chronic pancreatitis: systematic review and meta-analysis. Pain Physician. 2013;16:521–532.

    PubMed  Google Scholar 

  61. Zhou D, Wang W, Cheng X, et al. Antioxidant therapy for patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Nutr. 2015;34:627–634.

    Article  CAS  PubMed  Google Scholar 

  62. Rustagi T, Njei B. Antioxidant therapy for pain reduction in patients with chronic pancreatitis: a systematic review and meta-analysis. Pancreas. 2015;44:812–818.

    Article  CAS  PubMed  Google Scholar 

  63. Ahmed Ali U, Jens S, Busch OR, et al. Antioxidants for pain in chronic pancreatitis. Cochrane Database Syst Rev. 2014;8:CD008945.

    Google Scholar 

  64. Shalimar S, Midha S, Hasan A, et al. Long-term pain relief with optimized medical treatment including antioxidants and step-up interventional therapy in patients with chronic pancreatitis. J Gastroenterol Hepatol. 2017;32:270–277.

    Article  CAS  PubMed  Google Scholar 

  65. Rupasinghe SN, Siriwardena AK. Long-term outcome of patients with chronic pancreatitis treated with micronutrient antioxidant therapy. Hepatobiliary Pancreat Dis Int. 2017;16:209–214.

    Article  PubMed  Google Scholar 

  66. World Health Organization. Cancer Pain Relief. Geneva: World Health Organization; 1986.

    Google Scholar 

  67. Harden N, Cohen M. Unmet needs in the management of neuropathic pain. J Pain Symptom Manag. 2003;25:S12–S17.

    Article  Google Scholar 

  68. Siepsiak M, Szalek E, Karbownik A, et al. Pharmacokinetics of paracetamol in patients with chronic pancreatitis. Pharmacol Rep. 2016;68:733–736.

    Article  CAS  PubMed  Google Scholar 

  69. Kroon FP, van der Burg LR, Ramiro S, et al. Nonsteroidal anti-inflammatory drugs for axial spondyloarthritis: a Cochrane review. J Rheumatol. 2016;43:607–617.

    Article  CAS  PubMed  Google Scholar 

  70. Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105–118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Eriksen J, Sjogren P, Bruera E, et al. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125:172–179.

    Article  CAS  PubMed  Google Scholar 

  72. Gerson LB. Gastroenterologists and the US opioid epidemic. Gastroenterology. 2012;142:1250–1253.

    Article  PubMed  Google Scholar 

  73. Farmer AD, Gallagher J, Bruckner-Holt AC, et al. Narcotic bowel dysfunction. Lancet. Gastroenterol Hepatol. 2017;2:361–368.

    Google Scholar 

  74. http://www.choosingwisely.org/wp-content/uploads/2015/02/ASA-Pain-Medicine-Choosing-Wisely-List.pd. Last accessed on April 21, 2017.

  75. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315:1624–1645.

    Article  CAS  PubMed  Google Scholar 

  76. Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;348:1223–1232.

    Article  CAS  PubMed  Google Scholar 

  77. Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115:1363–1381.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Nielsen LM, Olesen AE, Branford R, et al. Association between human pain-related genotypes and variability in opioid analgesia. Pain Practice. 2015;15:580–594.

    Article  PubMed  Google Scholar 

  79. Somogyi AA, Coller JK, Barratt DT. Pharmacogenetics of opioid response. Clin Pharmacol Ther. 2015;97:125–127.

    Article  CAS  PubMed  Google Scholar 

  80. Dorn SD, Meek PD, Shah ND. Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics. Clin Gastroenterol Hepatol. 2011;9:1078–1085.

    Article  PubMed  Google Scholar 

  81. Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use—Unites States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66:265–269.

    Article  PubMed  Google Scholar 

  82. Barnett ML, Olenski AR, Jena AM. Opioid prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376:663–673.

    Article  PubMed  Google Scholar 

  83. Sorensen HT, Rasmussen HH, Moller-Petersen JF, et al. Epidemiology of pain requiring strong analgesics outside hospital in a geographically defined population in Denmark. Dan Med Bull. 1992;39:464–467.

    CAS  PubMed  Google Scholar 

  84. Lin TC, Ger LP, Pergolizzi JV, et al. Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: a cross-sectional study. J Formos Med Assoc. 2017;116:257–265.

    Article  PubMed  Google Scholar 

  85. Olesen SS, Poulsen JL, Broberg MC, et al. Opioid treatment and hypoalbuminemia are associated with increased hospitalization rates in chronic pancreatitis outpatients. Pancreatology. 2016;16:807–813.

    Article  CAS  PubMed  Google Scholar 

  86. Wilder-Smith CH, Hill L, Osler W, et al. Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci. 1999;44:1107–1116.

    Article  CAS  PubMed  Google Scholar 

  87. Sengupta JN, Su X, Gebhart GF, et al. Kappa, but not mu or delta, opioids attenuate responses to distension of afferent fibers innervating the rat colon. Gastroenterology. 1996;111:968–980.

    Article  CAS  PubMed  Google Scholar 

  88. Nozaki C, Kamei J. Involvement of the mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice. Eur J Pharmacol. 2007;560:160–162.

    Article  CAS  PubMed  Google Scholar 

  89. Staahl C, Dimcevski G, Andersen SD, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol. 2007;42:383–390.

    Article  CAS  PubMed  Google Scholar 

  90. Eisenach JC, Carpenter R, Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain. 2003;101:89–95.

    Article  CAS  PubMed  Google Scholar 

  91. Niemann T, Madsen LG, Larsen S, et al. Opioid treatment of painful chronic pancreatitis. Int J Pancreatol. 2000;27:235–240.

    Article  CAS  PubMed  Google Scholar 

  92. Grosen K, Olesen AE, Gram M, et al. Predictors of opioid efficacy in patients with chronic pain: a prospective multicenter observational cohort study. PLoS ONE. 2017;12:e0171723.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  93. Drossman DA. Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms. Am J Gastroenterol. 2009;104:2897–2902.

    Article  PubMed  Google Scholar 

  94. Olesen AE, Farmer AD, Olesen SS, et al. Management of chronic visceral pain. Pain Manag. 2016;6:469–486.

    Article  PubMed  Google Scholar 

  95. Sobin WH, Heinrich TW, Drossman DA. Central neuromodulators for treating functional GI disorders: a primer. Am J Gastroenterol. 2017 March 28 [Epub ahead of print].

  96. Tornblom H, Drossman DA. Centrally targeted pharmacotherapy for chronic abdominal pain; understanding and management. Handb Exp Pharmacol. 2017 Feb 16 [Epub ahead of print].

  97. Camilleri M, Boeckxstaens G. Dietary and pharmacological treatment of abdominal pain in IBS. Gut. 2017;66:966–974.

    Article  PubMed  Google Scholar 

  98. Olesen SS, Graversen C, Olesen AE, et al. Randomised clinical trial: pregabalin attenuated experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis. Aliment Pharmacol Ther. 2011;34:878–887.

    Article  CAS  PubMed  Google Scholar 

  99. Bouwense SA, Olesen SS, Drewes AM, et al. Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial. PLoS ONE. 2012;7:e42096.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Olesen SS, Bouwense SA, Wilder-Smith OH, et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology. 2011;141:536–543.

    Article  CAS  PubMed  Google Scholar 

  101. Olesen SS, Graversen C, Bouwense SA, et al. Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis. PLoS ONE. 2013;8:e57963.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Olesen AE, Olofsen E, Olesen SS, et al. The absorption profile of pregabalin in chronic pancreatitis. Basic Clin Pharmacol Toxicol. 2012;111:385–390.

    Article  CAS  PubMed  Google Scholar 

  103. Ahmed Ali U, Issa Y, Bruno MJ, et al. Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial. BMC Gastroenterol. 2013;13:49.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Talukdar R, Lakhtakia S, Reddy ND, et al. Ameliorating effect of antioxidants and pregabalin combination in pain recurrence after ductal clearance in chronic pancreatitis: results of a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol. 2016;31:1654–1662.

    Article  CAS  PubMed  Google Scholar 

  105. Bouwense SA, Buscher HC, van Goor H, et al. S-ketamine modulates hyperalgesia in patients with chronic pancreatitis pain. Reg Anesth Pain Med. 2011;36:303–307.

    Article  CAS  PubMed  Google Scholar 

  106. Juel J, Olesen SS, Olesen AE, et al. Study protocol for a randomized, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial). BMJ Open. 2015;5:e007087.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pancreatitis Center, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Vikesh K. Singh

  2. Mech-Sense, Centre for Pancreatic Diseases, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Mølleparkvej, 9000, Aalborg, Denmark

    Asbjørn M. Drewes

Authors
  1. Vikesh K. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asbjørn M. Drewes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vikesh K. Singh.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, V.K., Drewes, A.M. Medical Management of Pain in Chronic Pancreatitis. Dig Dis Sci 62, 1721–1728 (2017). https://doi.org/10.1007/s10620-017-4605-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4605-z

Keywords

Search

Navigation